• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
LFMD

LFMD

LifeMD, Inc.

NASDAQHealthcareMedical - PharmaceuticalsUS

USD4.56

-0.13 (-2.77%)

Rating:D+

Company Profile

CEO

Justin Schreiber

IPO Date

2008-01-29

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Exchange

NASDAQ

Country

US

Market Metrics

Open

$4.62

Prev. Close

$4.69

Day Low

$4.42

Day High

$4.64

52W Low

$2.56

52W High

$15.84

Market Cap

$0.22B

Volume

0.72M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

53.7%

Avg Negative

10.9%

Avg Neutral

35.4%

News Feed

LifeMD to Release Second Quarter 2021 Financial Results on Thursday, August 12, 2021

GlobeNewsWire·7/26/2021·↓ negative

LifeMD Teams with a Leading Provider of Diagnostic Services and Axle Health to Deliver Telehealth Access to At-Home Diagnostics

GlobeNewsWire·7/15/2021·↑ positive

LifeMD: 'Actual, Hard Numbers' Keep Us Bullish

Seeking Alpha·
7/13/2021
·↑ positive

LifeMD Names Experienced Pharma Executive Alexander Mironov as President

GlobeNewsWire·6/11/2021·↑ positive

LifeMD™ Completes $15M Debt Financing

GlobeNewsWire·6/3/2021·↑ positive

LifeMD to Present at Upcoming June Investor Conferences

GlobeNewsWire·5/28/2021·↑ positive

Plaintiffs in Shareholder Suits Drop Claims Against LifeMD

GlobeNewsWire·5/28/2021·↑ positive

CORRECTING and REPLACING Robbins Geller Rudman & Dowd LLP Announces Lead Plaintiff Deadline in the LifeMD, Inc. Class Action Lawsuit

Business Wire·5/19/2021·↓ negative

LifeMD™ Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewsWire·5/17/2021·↑ positive

LifeMD (LFMD) Stock: Over 24% Increase Explanation

Pulse2·5/14/2021·↑ positive